TW200514770A - Crystal of sulfonamide-containing indole compound and process for producing the same - Google Patents
Crystal of sulfonamide-containing indole compound and process for producing the sameInfo
- Publication number
- TW200514770A TW200514770A TW093126889A TW93126889A TW200514770A TW 200514770 A TW200514770 A TW 200514770A TW 093126889 A TW093126889 A TW 093126889A TW 93126889 A TW93126889 A TW 93126889A TW 200514770 A TW200514770 A TW 200514770A
- Authority
- TW
- Taiwan
- Prior art keywords
- sulfonamide
- crystal
- producing
- same
- indole compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003318953 | 2003-09-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200514770A true TW200514770A (en) | 2005-05-01 |
TWI349663B TWI349663B (zh) | 2011-10-01 |
Family
ID=34308544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093126889A TW200514770A (en) | 2003-09-10 | 2004-09-06 | Crystal of sulfonamide-containing indole compound and process for producing the same |
Country Status (25)
Country | Link |
---|---|
US (2) | US7754894B2 (zh) |
EP (1) | EP1666463B1 (zh) |
JP (1) | JP4435090B2 (zh) |
KR (1) | KR20060120644A (zh) |
CN (2) | CN101165049A (zh) |
AT (1) | ATE486849T1 (zh) |
AU (1) | AU2004272400B2 (zh) |
BR (1) | BRPI0414314A (zh) |
CA (1) | CA2536995C (zh) |
CY (1) | CY1110975T1 (zh) |
DE (1) | DE602004029907D1 (zh) |
DK (1) | DK1666463T3 (zh) |
ES (1) | ES2354286T3 (zh) |
HK (1) | HK1092796A1 (zh) |
HR (1) | HRP20100631T1 (zh) |
IL (2) | IL174059A0 (zh) |
MX (1) | MXPA06002732A (zh) |
NO (1) | NO335256B1 (zh) |
NZ (1) | NZ546111A (zh) |
PL (1) | PL1666463T3 (zh) |
PT (1) | PT1666463E (zh) |
RU (1) | RU2336269C2 (zh) |
SI (1) | SI1666463T1 (zh) |
TW (1) | TW200514770A (zh) |
WO (1) | WO2005026118A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004029907D1 (de) * | 2003-09-10 | 2010-12-16 | Eisai R&D Man Co Ltd | Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3868534B2 (ja) * | 1996-05-24 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド誘導体の製造法および中間体 |
JP2000247949A (ja) * | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
JP4039856B2 (ja) * | 2000-02-03 | 2008-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | インテグリン発現阻害剤 |
TWI283575B (en) * | 2000-10-31 | 2007-07-11 | Eisai Co Ltd | Medicinal compositions for concomitant use as anticancer agent |
DE602004029907D1 (de) * | 2003-09-10 | 2010-12-16 | Eisai R&D Man Co Ltd | Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung |
-
2004
- 2004-09-01 DE DE602004029907T patent/DE602004029907D1/de active Active
- 2004-09-01 RU RU2006111454/04A patent/RU2336269C2/ru not_active IP Right Cessation
- 2004-09-01 CN CNA2007101667949A patent/CN101165049A/zh active Pending
- 2004-09-01 EP EP04772605A patent/EP1666463B1/en active Active
- 2004-09-01 CN CNB2004800260696A patent/CN100406440C/zh not_active Expired - Fee Related
- 2004-09-01 NZ NZ546111A patent/NZ546111A/en not_active IP Right Cessation
- 2004-09-01 AU AU2004272400A patent/AU2004272400B2/en not_active Ceased
- 2004-09-01 CA CA2536995A patent/CA2536995C/en not_active Expired - Fee Related
- 2004-09-01 PL PL04772605T patent/PL1666463T3/pl unknown
- 2004-09-01 DK DK04772605.4T patent/DK1666463T3/da active
- 2004-09-01 US US10/571,279 patent/US7754894B2/en active Active
- 2004-09-01 KR KR1020067004877A patent/KR20060120644A/ko active Search and Examination
- 2004-09-01 WO PCT/JP2004/012649 patent/WO2005026118A1/ja active Application Filing
- 2004-09-01 JP JP2005513843A patent/JP4435090B2/ja not_active Expired - Fee Related
- 2004-09-01 ES ES04772605T patent/ES2354286T3/es active Active
- 2004-09-01 BR BRPI0414314-0A patent/BRPI0414314A/pt not_active IP Right Cessation
- 2004-09-01 SI SI200431578T patent/SI1666463T1/sl unknown
- 2004-09-01 MX MXPA06002732A patent/MXPA06002732A/es active IP Right Grant
- 2004-09-01 AT AT04772605T patent/ATE486849T1/de active
- 2004-09-01 PT PT04772605T patent/PT1666463E/pt unknown
- 2004-09-06 TW TW093126889A patent/TW200514770A/zh not_active IP Right Cessation
-
2006
- 2006-03-02 IL IL174059A patent/IL174059A0/en not_active IP Right Cessation
- 2006-04-05 NO NO20061545A patent/NO335256B1/no not_active IP Right Cessation
- 2006-12-06 HK HK06113378.9A patent/HK1092796A1/xx not_active IP Right Cessation
-
2009
- 2009-01-18 IL IL196569A patent/IL196569A0/en unknown
- 2009-06-09 US US12/480,959 patent/US20090247768A1/en not_active Abandoned
-
2010
- 2010-11-22 HR HR20100631T patent/HRP20100631T1/hr unknown
- 2010-12-10 CY CY20101101136T patent/CY1110975T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118637T1 (el) | Νεα κρυσταλλικη μορφη iii της αγομελατινης, μεθοδος παρασκευης αυτης και οι φαρμακευτικες συνθεσεις που την περιεχουν | |
AP1537A (en) | A crystalline form of perindopril tert-butylamine salt. | |
UA83720C2 (ru) | Кристаллическая форма v агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
RS54568B1 (en) | POLYMORPHIC FORMS OF RIFAXIMIN, PROCEDURES FOR ITS MANUFACTURE AND ITS USE IN MEDICINAL PRODUCTS | |
WO2009016462A3 (en) | Substituted bicyclolactam compounds | |
WO2006132914A3 (en) | Cyclobutyl amine derivatives | |
EA200701358A1 (ru) | Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина | |
UA83718C2 (ru) | Кристаллическая форма iv агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
TW200700398A (en) | Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds | |
EP1717238A4 (en) | FUNGICIDES HETEROCYCLIC COMPOUNDS | |
DE60325074D1 (de) | Kristall für ein orales, festes arzneimittel, und ein orales, festes arnzeimittel zur behandlung von dysurie, das diesen enthält | |
TW200611692A (en) | Processes for preparation of crystalline mycophenolate sodium | |
MY146028A (en) | Benzothiazole cyclobutyl amine derivatives | |
MY138547A (en) | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists | |
WO2007014839A3 (en) | Cathepsin k inhibitors | |
TW200514770A (en) | Crystal of sulfonamide-containing indole compound and process for producing the same | |
GB0425548D0 (en) | Radiolabelled ligands | |
TW200508239A (en) | Method for preparing polymorphism of irinotecan hydrochloride | |
MY136288A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
MY139289A (en) | Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
NO20063299L (no) | Syntese av en polymorf av 4-amino-5-klor-2-metoksy-N-(1-azabisyklo[3.3.1]non-4-yl)benzamidhydrokloridhydrat | |
WO2006110534A3 (en) | A process for preparing a crystalline form of halobetasol propionate | |
WO2005049589A3 (en) | Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases | |
WO2004069790A3 (en) | Crystalline modifications of triazinylaminostilbenes | |
TH112057B (th) | พอลิมอร์ฟของ n-ไฮดรอกซี่-3-[4-[[[2-(2-เมธิล-1h-อินดอล-3-อิล)เอธิล]อะมิโน[เมธิล]ฟีนิล]-2e-2-โพลพีนาไมด์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |